Reuters Health Report

Click to View in Browser 03/10/2014 Exclusive: Germany permits sale of Northwest Bio brain cancer drug (Reuters) - German health regulators have granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small U.S. biotechnology company has not yet completed its late-stage trial of the immunotherapy. Japanese researcher backtracks on 'breakthrough' STAP cell research TOKYO (Reuters) - A Japanese scientist called on Monday for withdrawing stem-cell research he had been involved in that had appeared to promise a new era of medical biology as doubts have arisen over the results. Heroin overdoses pose 'urgent public health crisis': U.S. attorney general WASHINGTON (Reuters) - U.S. Attorney General Eric Holder said his agency was stepping up efforts to stem sharp increases in deadly heroin overdoses, trafficking in the drug and abuse of prescription narcotics at the root of what he called an "urgent public health crisis." Caregivers often pick up phones at mealtime NEW YORK (Reuters Health) - Some parents pay more attention to their mobile devices than the kids they're supervising during meals, according to a new analysis. Proteus picks UK for 'smart pill' production and testing LONDON (Reuters) - A U.S. biotech company pioneering tablets containing edible embedded microchips that can tell if patients have taken their medication is to establish its first international manufacturing site in Britain. New hemophilia drugs aim to simplify treatment LOS ANGELES (Reuters) - For 33-year-old video editor and hemophilia patient Travis Roop, being able to get life-saving infusions of a blood clotting agent every two weeks, instead of rushing to treat a bleeding episode, meant he could jog for the first time. U.S. deadly pig virus cases on the rise (Reuters) - Cases of the deadly Porcine Epidemic Diarrhea virus, a highly contagious pig disease, are increasing across the U.S. farm belt, a group of animal health researchers said. Ranbaxy recalls some batches of generic Lipitor in latest quality blow MUMBAI (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd, reeling under a flurry of regulatory rebukes due to manufacturing quality concerns, has recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up was detected. LSD-laced steak sickened Florida family: medical examiner TAMPA, Fl. (Reuters) - A pregnant woman and her family were hospitalized this week after eating steak bought from a Wal-Mart that local authorities believed was laced with the hallucinogenic drug LSD, according to the medical examiner's initial test results. Study ties troubled sleep to lower brain volume NEW YORK (Reuters Health) - People who have trouble sleeping tend to have less volume in certain regions of the brain than those without sleep problems, a new study of Persian Gulf War veterans suggests. Related Video Finnish cars finish life as pots and pans Luxury driverless concept car offers view to the future The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend